Annotation_id
stringclasses 3
values | Claim_topic_id
stringclasses 516
values | Evidence_topic_id
stringlengths 21
35
| Claim_text
stringclasses 590
values | Label
stringclasses 3
values | Evidence Label
stringclasses 3
values | Evidence_text
stringlengths 12
794
⌀ | Article_topic_id
stringclasses 560
values | Reason
stringclasses 307
values |
|---|---|---|---|---|---|---|---|---|
C_2.2 | Claims_Covid_C2.2_167 | Evidence_Covid_C2.2_999 | WITH THIS BIONIC NOSE, COVID SURVIVORS MAY SMELL THE ROSES AGAIN | N | null | Right now, the team is focused on getting the sensors to detect more than a few odors and figuring out how best to interface with the brain. | covid_4325 | null |
C_2.2 | Claims_Covid_C2.2_167 | Evidence_Covid_C2.2_1000 | WITH THIS BIONIC NOSE, COVID SURVIVORS MAY SMELL THE ROSES AGAIN | N | null | ¡°I think we¡¯re several years away from cracking those nuts,¡± Costanzo says, ¡°but I think it¡¯s doable.¡± | covid_4325 | null |
C_2.2 | Claims_Covid_C2.2_167 | Evidence_Covid_C2.2_1001 | WITH THIS BIONIC NOSE, COVID SURVIVORS MAY SMELL THE ROSES AGAIN | N | null | When COVID struck, Moorehead saw an opportunity. Although they were far from having a product to advertise, he scrambled to put up a website for the startup. | covid_4325 | null |
C_2.2 | Claims_Covid_C2.2_167 | Evidence_Covid_C2.2_1002 | WITH THIS BIONIC NOSE, COVID SURVIVORS MAY SMELL THE ROSES AGAIN | N | null | Hummel estimates that the consortium¡¯s research could lead to a commercial product in 5 to 10 years. ¡°It¡¯s a question of effort and a question of funding,¡± he says. | covid_4325 | null |
C_2.2 | Claims_Covid_C2.2_168 | Evidence_Covid_C2.2_1003 | U.S. hospitals brace for an unprecedented winter of viruses | N | null | Hospitals nationwide are preparing for another winter with Covid ¡ª the first one that's also expected to include high levels of influenza and other respiratory illnesses that have simmered quietly in the background for the past two years. | covid_4326 | No enough supporting evidences found. |
C_2.2 | Claims_Covid_C2.2_168 | Evidence_Covid_C2.2_1004 | U.S. hospitals brace for an unprecedented winter of viruses | N | null | Flu cases are already rising in parts of the U.S., according to the Centers for Disease Control and Prevention. Pediatricians, too, are seeing a growing number of children sick with respiratory syncytial virus, or RSV, and enteroviruses. | covid_4326 | null |
C_2.2 | Claims_Covid_C2.2_168 | Evidence_Covid_C2.2_1005 | U.S. hospitals brace for an unprecedented winter of viruses | N | null | And despite a downward trend in Covid, tens of thousands of new cases are still being diagnosed every day. | covid_4326 | null |
C_2.2 | Claims_Covid_C2.2_168 | Evidence_Covid_C2.2_1006 | U.S. hospitals brace for an unprecedented winter of viruses | N | null | The convergence of viruses is hitting health care systems as they're forced to reckon with staffing shortages that worsened during the pandemic. | covid_4326 | null |
C_2.2 | Claims_Covid_C2.2_168 | Evidence_Covid_C2.2_1007 | U.S. hospitals brace for an unprecedented winter of viruses | N | null | If you go around the nation and ask hospitals how busy they are, every single one of them will tell you: They¡¯re busy, said Dr. Carlos del Rio, an executive associate dean at the Emory University School of Medicine and Grady Health System in Atlanta. | covid_4326 | null |
C_2.2 | Claims_Covid_C2.2_168 | Evidence_Covid_C2.2_1008 | U.S. hospitals brace for an unprecedented winter of viruses | N | null | There's no excess capacity in hospitals, del Rio said. "Anything that increases the number of patients is going to tip the scales." | covid_4326 | null |
C_2.2 | Claims_Covid_C2.2_169 | Evidence_Covid_C2.2_1009 | CDC Recommends the First Updated COVID-19 Booster | N | null | Today, CDC Director Rochelle P. Walensky, M.D., M.P.H., endorsed the CDC Advisory Committee on Immunization Practices¡¯ (ACIP) recommendations for use of updated COVID-19 boosters from Pfizer-BioNTech for people ages 12 years and older and from Moderna for people ages 18 years and older. | covid_4327 | No enough supporting evidences found. |
C_2.2 | Claims_Covid_C2.2_169 | Evidence_Covid_C2.2_1010 | CDC Recommends the First Updated COVID-19 Booster | N | null | In the coming weeks, CDC also expects to recommend updated COVID-19 boosters for other pediatric groups, per the discussion and evaluation of the data by ACIP on Sept. 1, 2022. | covid_4327 | null |
C_2.2 | Claims_Covid_C2.2_169 | Evidence_Covid_C2.2_1011 | CDC Recommends the First Updated COVID-19 Booster | N | null | When data are available and FDA authorizes these other types of COVID-19 boosters, CDC will quickly move to help make them available in the United States. | covid_4327 | null |
C_2.2 | Claims_Covid_C2.2_169 | Evidence_Covid_C2.2_1012 | CDC Recommends the First Updated COVID-19 Booster | N | null | The updated COVID-19 boosters are formulated to better protect against the most recently circulating COVID-19 variant. | covid_4327 | null |
C_2.2 | Claims_Covid_C2.2_169 | Evidence_Covid_C2.2_1013 | CDC Recommends the First Updated COVID-19 Booster | N | null | They can help restore protection that has waned since previous vaccination and were designed to provide broader protection against newer variants. | covid_4327 | null |
C_2.2 | Claims_Covid_C2.2_169 | Evidence_Covid_C2.2_1014 | CDC Recommends the First Updated COVID-19 Booster | N | null | This recommendation followed a comprehensive scientific evaluation and robust scientific discussion. If you are eligible, there is no bad time to get your COVID-19 booster and I strongly encourage you to receive it. | covid_4327 | null |
C_2.2 | Claims_Covid_C2.2_170 | Evidence_Covid_C2.2_1015 | New data shows long Covid is keeping as many as 4 million people out of work | N | null | In January 2022, Brookings Metro published a report that assessed the impact of long Covid on the labor market. Data on the condition¡¯s prevalence was limited, so the report used various studies to make a conservative estimate: 1.6 million full-time equivalent workers could be out of work due to long Covid. | covid_4328 | No enough supporting evidences found. |
C_2.2 | Claims_Covid_C2.2_170 | Evidence_Covid_C2.2_1016 | New data shows long Covid is keeping as many as 4 million people out of work | N | null | With 10.6 million unfilled jobs at the time, long Covid potentially accounted for 15% of the labor shortage. | covid_4328 | null |
C_2.2 | Claims_Covid_C2.2_170 | Evidence_Covid_C2.2_1017 | New data shows long Covid is keeping as many as 4 million people out of work | N | null | Around 16 million working-age Americans (those aged 18 to 65) have long Covid today. | covid_4328 | null |
C_2.2 | Claims_Covid_C2.2_170 | Evidence_Covid_C2.2_1018 | New data shows long Covid is keeping as many as 4 million people out of work | N | null | Of those, 2 to 4 million are out of work due to long Covid. | covid_4328 | null |
C_2.2 | Claims_Covid_C2.2_170 | Evidence_Covid_C2.2_1019 | New data shows long Covid is keeping as many as 4 million people out of work | N | null | The Census Bureau¡¯s June to July 2022 HPS survey found that 16.3 million people (around 8%) of working-age Americans currently have long Covid. | covid_4328 | null |
C_2.2 | Claims_Covid_C2.2_170 | Evidence_Covid_C2.2_1020 | New data shows long Covid is keeping as many as 4 million people out of work | N | null | As many as 4 million workers are likely out of work due to long Covid | covid_4328 | null |
C_2.2 | Claims_Covid_C2.2_171 | Evidence_Covid_C2.2_1021 | New HHS Repor Underscoring Importance of Getting Updated COVID-19 Vaccines This Fall | N | null | A new report from the U.S. Department of Health and Human Services (HHS) shows that the Biden Administration's historic vaccination program, which has gotten over 90 percent of seniors fully vaccinated and over 70 percent of seniors a booster shot, is linked to more than 650,000 fewer COVID-19 hospitalizations and more than 300,000 fewer deaths among seniors and other Americans enrolled in Medicare. | covid_4331 | No enough supporting evidences found. |
C_2.2 | Claims_Covid_C2.2_171 | Evidence_Covid_C2.2_1022 | New HHS Repor Underscoring Importance of Getting Updated COVID-19 Vaccines This Fall | N | null | The study, which was conducted by researchers with HHS's Office of the Assistant Secretary for Planning and Evaluation (ASPE), underscores the importance of Americans ¨C particularly seniors and others at high-risk of serious outcomes ¨C getting an updated COVID-19 vaccine this fall. | covid_4331 | null |
C_2.2 | Claims_Covid_C2.2_171 | Evidence_Covid_C2.2_1023 | New HHS Repor Underscoring Importance of Getting Updated COVID-19 Vaccines This Fall | N | null | This report reaffirms what we have said all along: COVID-19 vaccines save lives and prevent hospitalizations, said HHS Secretary Xavier Becerra. | covid_4331 | null |
C_2.2 | Claims_Covid_C2.2_171 | Evidence_Covid_C2.2_1024 | New HHS Repor Underscoring Importance of Getting Updated COVID-19 Vaccines This Fall | N | null | We now have updated COVID vaccines designed to protect you against the Omicron strain of COVID that makes up almost all COVID cases in the U.S. | covid_4331 | null |
C_2.2 | Claims_Covid_C2.2_171 | Evidence_Covid_C2.2_1025 | New HHS Repor Underscoring Importance of Getting Updated COVID-19 Vaccines This Fall | N | null | Over 90 percent of Americans live within 5 miles of where they can access these vaccines for free. I urge everyone eligible to get an updated COVID vaccine to protect yourself ahead of the fall and winter. | covid_4331 | null |
C_2.2 | Claims_Covid_C2.2_171 | Evidence_Covid_C2.2_1026 | New HHS Repor Underscoring Importance of Getting Updated COVID-19 Vaccines This Fall | N | null | All racial and ethnic groups and all 50 states experienced reduced numbers of COVID-19 deaths and hospitalizations linked to vaccination, highlighting the importance of achieving high levels of vaccinations in the US to save lives. | covid_4331 | null |
C_2.2 | Claims_Covid_C2.2_172 | Evidence_Covid_C2.2_1027 | High levels of immunity and availability of effective COVID-19 prevention and management tools have reduced the risk for medically significant illness and death. | N | null | Medically significant illness, death, and health care system strain can be reduced through vaccination and therapeutics to prevent severe illness, complemented by use of multiple prevention methods to reduce exposure risk and an emphasis on protecting persons at high risk for severe illness. | covid_4332 | No enough supporting evidences found. |
C_2.2 | Claims_Covid_C2.2_172 | Evidence_Covid_C2.2_1028 | High levels of immunity and availability of effective COVID-19 prevention and management tools have reduced the risk for medically significant illness and death. | N | null | As SARS-CoV-2, the virus that causes COVID-19, continues to circulate globally, high levels of vaccine- and infection-induced immunity and the availability of effective treatments and prevention tools have substantially reduced the risk for medically significant COVID-19 illness (severe acute illness and post¨CCOVID-19 conditions) and associated hospitalization and death (1). | covid_4332 | null |
C_2.2 | Claims_Covid_C2.2_172 | Evidence_Covid_C2.2_1029 | High levels of immunity and availability of effective COVID-19 prevention and management tools have reduced the risk for medically significant illness and death. | N | null | These circumstances now allow public health efforts to minimize the individual and societal health impacts of COVID-19 by focusing on sustainable measures to further reduce medically significant illness as well as to minimize strain on the health care system, while reducing barriers to social, educational, and economic activity (2). | covid_4332 | null |
C_2.2 | Claims_Covid_C2.2_172 | Evidence_Covid_C2.2_1030 | High levels of immunity and availability of effective COVID-19 prevention and management tools have reduced the risk for medically significant illness and death. | N | null | Exposure risk can be mitigated through nonpharmaceutical interventions, including improving ventilation, use of masks or respirators indoors, and testing (4). The risk for medically significant illness increases with age, disability status, and underlying medical conditions but is considerably reduced by immunity derived from vaccination, previous infection, or both, as well as timely access to effective biomedical prevention measures and treatments (3,5). | covid_4332 | null |
C_2.2 | Claims_Covid_C2.2_172 | Evidence_Covid_C2.2_1031 | High levels of immunity and availability of effective COVID-19 prevention and management tools have reduced the risk for medically significant illness and death. | N | null | COVID-19 vaccines are highly protective against severe illness and death and provide a lesser degree of protection against asymptomatic and mild infection (6). | covid_4332 | null |
C_2.2 | Claims_Covid_C2.2_172 | Evidence_Covid_C2.2_1032 | High levels of immunity and availability of effective COVID-19 prevention and management tools have reduced the risk for medically significant illness and death. | N | null | COVID-19 remains an ongoing public health threat; however, high levels of vaccine- and infection-induced immunity and the availability of medical and nonpharmaceutical interventions have substantially reduced the risk for medically significant illness, hospitalization, and death from COVID-19. | covid_4332 | null |
C_2.2 | Claims_Covid_C2.2_173 | Evidence_Covid_C2.2_1033 | FDA Authorizes Emergency Use of Novavax COVID-19 Vaccine, Adjuvanted | N | null | Today, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the Novavax COVID-19 Vaccine, Adjuvanted for the prevention of COVID-19 caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in individuals 18 years of age and older. | covid_4333 | No enough supporting evidences found. |
C_2.2 | Claims_Covid_C2.2_173 | Evidence_Covid_C2.2_1034 | FDA Authorizes Emergency Use of Novavax COVID-19 Vaccine, Adjuvanted | N | null | ¡°Authorizing an additional COVID-19 vaccine expands the available vaccine options for the prevention of COVID-19, including the most severe outcomes that can occur such as hospitalization and death,¡± said FDA Commissioner Robert M. Califf, M.D. | covid_4333 | null |
C_2.2 | Claims_Covid_C2.2_173 | Evidence_Covid_C2.2_1035 | FDA Authorizes Emergency Use of Novavax COVID-19 Vaccine, Adjuvanted | N | null | Today¡¯s authorization offers adults in the United States who have not yet received a COVID-19 vaccine another option that meets the FDA¡¯s rigorous standards for safety, effectiveness and manufacturing quality needed to support emergency use authorization. | covid_4333 | null |
C_2.2 | Claims_Covid_C2.2_173 | Evidence_Covid_C2.2_1036 | FDA Authorizes Emergency Use of Novavax COVID-19 Vaccine, Adjuvanted | N | null | COVID-19 vaccines remain the best preventive measure against severe disease caused by COVID-19 and I encourage anyone who is eligible for, but has not yet received a COVID-19 vaccine, to consider doing so. | covid_4333 | null |
C_2.2 | Claims_Covid_C2.2_173 | Evidence_Covid_C2.2_1037 | FDA Authorizes Emergency Use of Novavax COVID-19 Vaccine, Adjuvanted | N | null | The FDA has determined that the Novavax COVID-19 Vaccine, Adjuvanted has met the statutory criteria for issuance of an EUA. | covid_4333 | null |
C_2.2 | Claims_Covid_C2.2_173 | Evidence_Covid_C2.2_1038 | FDA Authorizes Emergency Use of Novavax COVID-19 Vaccine, Adjuvanted | N | null | In making this determination, the FDA can assure the public and medical community that a thorough analysis and evaluation of the available safety and effectiveness data and manufacturing information have been conducted. | covid_4333 | null |
C_2.2 | Claims_Covid_C2.2_174 | Evidence_Covid_C2.2_1039 | The US is on a Covid plateau, and no one¡¯s sure what will happen next | N | null | The United States seems to have hit a Covid-19 plateau, with more than 40,000 people hospitalized and more than 400 deaths a day consistently over the past month or so. | covid_4336 | No enough supporting evidences found. |
C_2.2 | Claims_Covid_C2.2_174 | Evidence_Covid_C2.2_1040 | The US is on a Covid plateau, and no one¡¯s sure what will happen next | N | null | And there are big question marks around what might happen next, as the coronavirus¡¯ evolution remains quite elusive 2? years into the pandemic. | covid_4336 | null |
C_2.2 | Claims_Covid_C2.2_174 | Evidence_Covid_C2.2_1041 | The US is on a Covid plateau, and no one¡¯s sure what will happen next | N | null | ¡°We¡¯ve never really cracked that: why these surges go up and down, how long it stays up and how fast it comes down,¡± said Dr. Eric Topol, a cardiologist and professor of molecular medicine at Scripps Research. ¡°All these things are still somewhat of a mystery.¡± | covid_4336 | null |
C_2.2 | Claims_Covid_C2.2_174 | Evidence_Covid_C2.2_1042 | The US is on a Covid plateau, and no one¡¯s sure what will happen next | N | null | But the plateau in hospitalizations is ¡°encouraging¡± because it means the subvariant probably has worked its way through most of the hosts it can find. | covid_4336 | null |
C_2.2 | Claims_Covid_C2.2_174 | Evidence_Covid_C2.2_1043 | The US is on a Covid plateau, and no one¡¯s sure what will happen next | N | null | ¡°Right now, the question is what comes as we descend from BA.5. It could take weeks.¡± | covid_4336 | null |
C_2.2 | Claims_Covid_C2.2_174 | Evidence_Covid_C2.2_1044 | The US is on a Covid plateau, and no one¡¯s sure what will happen next | N | null | CDC ensemble forecasts predict stable trends in hospitalizations and deaths over the coming weeks, and experts agree that the worst of the wave has probably passed. | covid_4336 | null |
C_2.2 | Claims_Covid_C2.2_175 | Evidence_Covid_C2.2_1045 | Biden¨CHarris Administration Releases Two New Reports on Long COVID to Support Patients and Further Research | N | null | In April, President Joe Biden issued a Memorandum on Addressing the Long-Term Effects of COVID-19, which called for the creation of two reports. | covid_4337 | No enough supporting evidences found. |
C_2.2 | Claims_Covid_C2.2_175 | Evidence_Covid_C2.2_1046 | Biden¨CHarris Administration Releases Two New Reports on Long COVID to Support Patients and Further Research | N | null | Within 120 days, the U.S. Department of Health and Human Services (HHS), leading a whole-of-government response, developed two reports that together, pave an actionable path forward to address Long COVID and associated conditions. | covid_4337 | null |
C_2.2 | Claims_Covid_C2.2_175 | Evidence_Covid_C2.2_1047 | Biden¨CHarris Administration Releases Two New Reports on Long COVID to Support Patients and Further Research | N | null | The National Research Action Plan on Long COVID details advances in current research and charts a course for future study to better understand prevention and treatment of Long COVID. | covid_4337 | null |
C_2.2 | Claims_Covid_C2.2_175 | Evidence_Covid_C2.2_1048 | Biden¨CHarris Administration Releases Two New Reports on Long COVID to Support Patients and Further Research | N | null | The Services and Supports for Longer-Term Impacts of COVID-19 report highlights resources for health care workers, and those effected by broader effects of COVID-19, including not only Long COVID but also effects on mental health and substance use, and loss of caregivers and loved ones. | covid_4337 | null |
C_2.2 | Claims_Covid_C2.2_175 | Evidence_Covid_C2.2_1049 | Biden¨CHarris Administration Releases Two New Reports on Long COVID to Support Patients and Further Research | N | null | ¡°Long COVID can hinder an individual¡¯s ability to work, attend school, participate in community life, and engage in everyday activities,¡± said HHS Secretary Xavier Becerra. ¡°As our nation continues to make strides in the fight against COVID-19, these reports are critical to shine a light on Long COVID¡¯s impact and how to match people to resources.¡± | covid_4337 | null |
C_2.2 | Claims_Covid_C2.2_175 | Evidence_Covid_C2.2_1050 | Biden¨CHarris Administration Releases Two New Reports on Long COVID to Support Patients and Further Research | N | null | ¡°The Biden-Harris Administration is committed to combating and responding to the COVID-19 pandemic with the full capacity of the federal government,¡± said HHS Assistant Secretary for Health ADM Rachel Levine. "These initial reports are an important step as HHS continues to accelerate research and programmatic support to address the consequences of the pandemic and work across sectors to ensure no one is left behind as we continue to build a healthier future.¡± | covid_4337 | null |
C_2.2 | Claims_Covid_C2.2_176 | Evidence_Covid_C2.2_1051 | Rising Covid-19 cases in the UK may be a warning for the US | N | null | There are signs that the United Kingdom could be heading into a fall Covid-19 wave, and experts say the United States may not be far behind. | covid_4338 | No enough supporting evidences found. |
C_2.2 | Claims_Covid_C2.2_176 | Evidence_Covid_C2.2_1052 | Rising Covid-19 cases in the UK may be a warning for the US | N | null | ¡°Generally, what happens in the UK is reflected about a month later in the US. I think this is what I¡¯ve sort of been seeing,¡± said Dr. Tim Spector, professor of genetic epidemiology at Kings College London. | covid_4338 | null |
C_2.2 | Claims_Covid_C2.2_176 | Evidence_Covid_C2.2_1053 | Rising Covid-19 cases in the UK may be a warning for the US | N | null | Spector runs the Zoe Health Study, which uses an app to let people in the UK and US report their daily symptoms. | covid_4338 | null |
C_2.2 | Claims_Covid_C2.2_176 | Evidence_Covid_C2.2_1054 | Rising Covid-19 cases in the UK may be a warning for the US | N | null | Spector says the study, which has been running since the days of the first lockdown in England in 2020, has accurately captured the start of each wave, and its numbers run about one to two weeks ahead of official government statistics. | covid_4338 | null |
C_2.2 | Claims_Covid_C2.2_176 | Evidence_Covid_C2.2_1055 | Rising Covid-19 cases in the UK may be a warning for the US | N | null | After seeing a downward trend for the past few weeks, the Zoe study saw a 30% increase in reported Covid-19 cases within the past week. | covid_4338 | null |
C_2.2 | Claims_Covid_C2.2_176 | Evidence_Covid_C2.2_1056 | Rising Covid-19 cases in the UK may be a warning for the US | N | null | On Friday, that increase was reflected in official UK government data too, although it was not as large as the increases reported by Zoe loggers. | covid_4338 | null |
C_2.2 | Claims_Covid_C2.2_177 | Evidence_Covid_C2.2_1057 | CDC Strengthens Recommendations and Expands Eligibility for COVID-19 Booster Shots | N | null | Following today¡¯s meeting of the Advisory Committee on Immunization Practices¡¯ (ACIP), CDC is expanding eligibility of COVID-19 vaccine booster doses to everyone 5 years of age and older. | covid_4339 | No enough supporting evidences found. |
C_2.2 | Claims_Covid_C2.2_177 | Evidence_Covid_C2.2_1058 | CDC Strengthens Recommendations and Expands Eligibility for COVID-19 Booster Shots | N | null | CDC now recommends that children ages 5 through 11 years should receive a booster shot 5 months after their initial Pfizer-BioNTech vaccination series. | covid_4339 | null |
C_2.2 | Claims_Covid_C2.2_177 | Evidence_Covid_C2.2_1059 | CDC Strengthens Recommendations and Expands Eligibility for COVID-19 Booster Shots | N | null | As cases increase across the country, a booster dose will safely help restore and enhance protection against severe disease. | covid_4339 | null |
C_2.2 | Claims_Covid_C2.2_177 | Evidence_Covid_C2.2_1060 | CDC Strengthens Recommendations and Expands Eligibility for COVID-19 Booster Shots | N | null | In addition, today CDC is strengthening its recommendation that those 12 and older who are immunocompromised and those 50 and older should receive a second booster dose at least 4 months after their first. | covid_4339 | null |
C_2.2 | Claims_Covid_C2.2_177 | Evidence_Covid_C2.2_1061 | CDC Strengthens Recommendations and Expands Eligibility for COVID-19 Booster Shots | N | null | Whether it is your first booster, or your second, if you haven¡¯t had a vaccine dose since the beginning of December 2021 and you are eligible, now is the time to get one. | covid_4339 | null |
C_2.2 | Claims_Covid_C2.2_177 | Evidence_Covid_C2.2_1062 | CDC Strengthens Recommendations and Expands Eligibility for COVID-19 Booster Shots | N | null | With cases increasing, it is important that all people have the protection they need, which is why, today, CDC has also strengthened another booster recommendation. | covid_4339 | null |
C_2.2 | Claims_Covid_C2.2_178 | Evidence_Covid_C2.2_1063 | CDC Recommends COVID-19 Vaccines for Young Children | N | null | Today, CDC Director Rochelle P. Walensky, M.D., M.P.H., endorsed the Advisory Committee on Immunization Practices¡¯ (ACIP) recommendation that all children 6 months through 5 years of age should receive a COVID-19 vaccine. | covid_4340 | No enough supporting evidences found. |
C_2.2 | Claims_Covid_C2.2_178 | Evidence_Covid_C2.2_1064 | CDC Recommends COVID-19 Vaccines for Young Children | N | null | This expands eligibility for vaccination to nearly 20 million additional children and means that all Americans ages 6 months and older are now eligible for vaccination. | covid_4340 | null |
C_2.2 | Claims_Covid_C2.2_178 | Evidence_Covid_C2.2_1065 | CDC Recommends COVID-19 Vaccines for Young Children | N | null | Parents and caregivers can now get their children 6 months through 5 years of age vaccinated with the Pfizer-BioNTech or Moderna vaccines to better protect them from COVID-19. | covid_4340 | null |
C_2.2 | Claims_Covid_C2.2_178 | Evidence_Covid_C2.2_1066 | CDC Recommends COVID-19 Vaccines for Young Children | N | null | All children, including children who have already had COVID-19, should get vaccinated. | covid_4340 | null |
C_2.2 | Claims_Covid_C2.2_178 | Evidence_Covid_C2.2_1067 | CDC Recommends COVID-19 Vaccines for Young Children | N | null | Children in this younger age group can be vaccinated with whichever vaccine is available (either Moderna or Pfizer-BioNTech). | covid_4340 | null |
C_2.2 | Claims_Covid_C2.2_178 | Evidence_Covid_C2.2_1068 | CDC Recommends COVID-19 Vaccines for Young Children | N | null | I encourage parents and caregivers with questions to talk to their doctor, nurse, or local pharmacist to learn more about the benefits of vaccinations and the importance of protecting their children by getting them vaccinated. | covid_4340 | null |
C_2.2 | Claims_Covid_C2.2_179 | Evidence_Covid_C2.2_1069 | Children and adolescents might be at risk for certain post-COVID symptoms and conditions. | N | null | Compared with patients aged 0¨C17 years without previous COVID-19, those with previous COVID-19 had higher rates of acute pulmonary embolism (adjusted hazard ratio = 2.01), myocarditis and cardiomyopathy (1.99), venous thromboembolic event (1.87), acute and unspecified renal failure (1.32), and type 1 diabetes (1.23), all of which were rare or uncommon in this study population. | covid_4342 | No enough supporting evidences found. |
C_2.2 | Claims_Covid_C2.2_179 | Evidence_Covid_C2.2_1070 | Children and adolescents might be at risk for certain post-COVID symptoms and conditions. | N | null | The analysis identified several symptoms and conditions with elevated adjusted hazard ratios among patients with COVID-19 (compared with those without). The highest hazard ratios were recorded for acute pulmonary embolism (adjusted hazard ratio [aHR] = 2.01), myocarditis and cardiomyopathy (1.99), venous thromboembolic event (1.87), acute and unspecified renal failure (1.32), and type 1 diabetes (1.23), all of which were rare or uncommon in this study population. | covid_4342 | null |
C_2.2 | Claims_Covid_C2.2_179 | Evidence_Covid_C2.2_1071 | Children and adolescents might be at risk for certain post-COVID symptoms and conditions. | N | null | Conversely, symptoms and conditions that were most common in this study population had lower aHRs (near or below 1.0). Patients with COVID-19 were less likely than were patients without to experience respiratory signs and symptoms, symptoms of mental conditions, muscle disorders, neurological conditions, anxiety and fear-related disorders, mood disorders, and sleeping disorders. | covid_4342 | null |
C_2.2 | Claims_Covid_C2.2_179 | Evidence_Covid_C2.2_1072 | Children and adolescents might be at risk for certain post-COVID symptoms and conditions. | N | null | Among children aged 2¨C4 years, the highest aHRs for patients with COVID-19 compared with patients without COVID-19 were for myocarditis and cardiomyopathy (aHR = 2.39), acute and unspecified renal failure (1.52), and coagulation and hemorrhagic disorders (1.47) (Table 3). Unlike other age groups, children aged 2¨C4 years had higher rates of asthma diagnosis (1.12) and respiratory signs and symptoms (1.07) after COVID-19. | covid_4342 | null |
C_2.2 | Claims_Covid_C2.2_179 | Evidence_Covid_C2.2_1073 | Children and adolescents might be at risk for certain post-COVID symptoms and conditions. | N | null | Among children aged 5¨C11 years, the highest aHRs for patients with COVID-19 compared with those without were for myocarditis and cardiomyopathy (2.84), venous thromboembolic event (2.69), and acute and unspecified renal failure (1.38). | covid_4342 | null |
C_2.2 | Claims_Covid_C2.2_179 | Evidence_Covid_C2.2_1074 | Children and adolescents might be at risk for certain post-COVID symptoms and conditions. | N | null | Among patients aged 12¨C17 years, the highest aHRs for those with COVID-19 compared with those without were for acute pulmonary embolism (2.03), myocarditis and cardiomyopathy (1.66), and venous thromboembolic event (1.52). | covid_4342 | null |
C_2.2 | Claims_Covid_C2.2_180 | Evidence_Covid_C2.2_1075 | End of Covid-19 pandemic is in sight, WHO director-general says, ¡®so let¡¯s seize this opportunity¡¯ | N | null | The world has never been in a better position to end the Covid-19 pandemic, Tedros Adhanom Ghebreyesus, director-general of the World Health Organization, said in a news briefing in Geneva on Wednesday. | covid_4343 | No enough supporting evidences found. |
C_2.2 | Claims_Covid_C2.2_180 | Evidence_Covid_C2.2_1076 | End of Covid-19 pandemic is in sight, WHO director-general says, ¡®so let¡¯s seize this opportunity¡¯ | N | null | ¡°Last week, the number of weekly reported deaths from Covid-19 was the lowest since March 2020,¡± he said. ¡°We have never been in a better position to end the pandemic. We¡¯re not there yet, but the end is in sight. | covid_4343 | null |
C_2.2 | Claims_Covid_C2.2_180 | Evidence_Covid_C2.2_1077 | End of Covid-19 pandemic is in sight, WHO director-general says, ¡®so let¡¯s seize this opportunity¡¯ | N | null | There is still a risk of more variants, deaths, disruption and uncertainty, he said, ¡°so let¡¯s seize this opportunity.¡± | covid_4343 | null |
C_2.2 | Claims_Covid_C2.2_180 | Evidence_Covid_C2.2_1078 | End of Covid-19 pandemic is in sight, WHO director-general says, ¡®so let¡¯s seize this opportunity¡¯ | N | null | They are ¡°an urgent call for governments to take a hard look at their policies and strengthen them for Covid-19 and future pathogens with pandemic potential,¡± Tedros said. | covid_4343 | null |
C_2.2 | Claims_Covid_C2.2_180 | Evidence_Covid_C2.2_1079 | End of Covid-19 pandemic is in sight, WHO director-general says, ¡®so let¡¯s seize this opportunity¡¯ | N | null | Although official case counts have become significantly underreported, trends have shown a steady drop in cases both globally and in the US. | covid_4343 | null |
C_2.2 | Claims_Covid_C2.2_180 | Evidence_Covid_C2.2_1080 | End of Covid-19 pandemic is in sight, WHO director-general says, ¡®so let¡¯s seize this opportunity¡¯ | N | null | According to latest WHO update, weekly case counts are falling in all regions, with an overall fall of 28% compared to a week before. | covid_4343 | null |
C_2.2 | Claims_Covid_C2.2_181 | Evidence_Covid_C2.2_1081 | CDC Recommends Novavax COVID-19 Vaccine for Adolescents | N | null | Today, CDC Director Rochelle P. Walensky, M.D., M.P.H., signed a decision memo that Novavax¡¯s COVID-19 vaccine be used as another primary series option for adolescents ages 12 through 17. | covid_4345 | No enough supporting evidences found. |
C_2.2 | Claims_Covid_C2.2_181 | Evidence_Covid_C2.2_1082 | CDC Recommends Novavax COVID-19 Vaccine for Adolescents | N | null | This recommendation follows FDA¡¯s authorization to authorize the vaccine for this age group under emergency use. | covid_4345 | null |
C_2.2 | Claims_Covid_C2.2_181 | Evidence_Covid_C2.2_1083 | CDC Recommends Novavax COVID-19 Vaccine for Adolescents | N | null | Novavax¡¯s COVID-19 vaccine, which is available now, is an important tool in the pandemic and provides a more familiar type of COVID-19 vaccine technology for adolescents. Having multiple types of vaccines offers more options and flexibility for the public, jurisdictions, and vaccine providers. | covid_4345 | null |
C_2.2 | Claims_Covid_C2.2_181 | Evidence_Covid_C2.2_1084 | CDC Recommends Novavax COVID-19 Vaccine for Adolescents | N | null | Novavax¡¯s COVID-19 vaccine packages harmless proteins of the COVID-19 virus alongside another ingredient called an adjuvant that helps the immune system respond to the virus in the future. | covid_4345 | null |
C_2.2 | Claims_Covid_C2.2_181 | Evidence_Covid_C2.2_1085 | CDC Recommends Novavax COVID-19 Vaccine for Adolescents | N | null | Vaccines¡ªlike the Novavax COVID-19 vaccine¡ªthat use protein subunit technology have been used for more than 30 years in the United States, beginning with the first licensed hepatitis B vaccine. | covid_4345 | null |
C_2.2 | Claims_Covid_C2.2_181 | Evidence_Covid_C2.2_1086 | CDC Recommends Novavax COVID-19 Vaccine for Adolescents | N | null | Other protein subunit vaccines used in the United States today include those to protect against influenza and whooping cough (acellular pertussis). | covid_4345 | null |
C_2.2 | Claims_Covid_C2.2_182 | Evidence_Covid_C2.2_1087 | President Joe Biden tests positive for Covid-19 again | N | null | President Joe Biden tested positive for Covid-19 again Saturday morning, per a letter from presidential physician Dr. Kevin O¡¯Connor, in what is likely a ¡°rebound¡± Covid-19 positivity that the doctor noted is ¡°observed in a small percentage of patients treated with Paxlovid.¡± | covid_4346 | No enough supporting evidences found. |
C_2.2 | Claims_Covid_C2.2_182 | Evidence_Covid_C2.2_1088 | President Joe Biden tests positive for Covid-19 again | N | null | O¡¯Connor said the President tested negative on Tuesday evening, Wednesday morning, Thursday morning and Friday morning before testing positive on Saturday morning. | covid_4346 | null |
C_2.2 | Claims_Covid_C2.2_182 | Evidence_Covid_C2.2_1089 | President Joe Biden tests positive for Covid-19 again | N | null | ¡°However, given his positive antigen test, he will reinitiate strict isolation procedures,¡± the doctor noted. | covid_4346 | null |
C_2.2 | Claims_Covid_C2.2_182 | Evidence_Covid_C2.2_1090 | President Joe Biden tests positive for Covid-19 again | N | null | ¡°Folks, today I tested positive for COVID again,¡± Biden wrote on Twitter. ¡°This happens with a small minority of folks. I¡¯ve got no symptoms but I am going to isolate for the safety of everyone around me. I¡¯m still at work, and will be back on the road soon.¡± | covid_4346 | null |
C_2.2 | Claims_Covid_C2.2_182 | Evidence_Covid_C2.2_1091 | President Joe Biden tests positive for Covid-19 again | N | null | White House press secretary Karine Jean-Pierre wrote Biden is ¡°asymptomatic, feeling fine, and working in isolation from the Residence to protect others.¡± | covid_4346 | null |
C_2.2 | Claims_Covid_C2.2_182 | Evidence_Covid_C2.2_1092 | President Joe Biden tests positive for Covid-19 again | N | null | A White House official said contact tracing efforts were underway Saturday after Biden¡¯s positive Covid-19 test. | covid_4346 | null |
C_2.2 | Claims_Covid_C2.2_183 | Evidence_Covid_C2.2_1093 | Dr. Fauci: A new, more dangerous Covid variant could emerge this winter | N | null | Dr. Anthony Fauci has a sober warning for Americans: Don¡¯t be surprised if a new, more dangerous Covid variant emerges this upcoming winter. | covid_4347 | No enough supporting evidences found. |
C_2.2 | Claims_Covid_C2.2_183 | Evidence_Covid_C2.2_1094 | Dr. Fauci: A new, more dangerous Covid variant could emerge this winter | N | null | ¡°We should anticipate that we very well may get another variant that would emerge, that would elude the immune response that we¡¯ve gotten from infection and/or from vaccination,¡± Fauci said at an event with the USC Annenberg Center for Health Journalism this week. | covid_4347 | null |
C_2.2 | Claims_Covid_C2.2_183 | Evidence_Covid_C2.2_1095 | Dr. Fauci: A new, more dangerous Covid variant could emerge this winter | N | null | But Fauci urged Americans not to let their guard down because there¡¯s always a ¡°risk of uptick¡± in the winter months. | covid_4347 | null |
C_2.2 | Claims_Covid_C2.2_183 | Evidence_Covid_C2.2_1096 | Dr. Fauci: A new, more dangerous Covid variant could emerge this winter | N | null | ¡°It looks like we¡¯re going in the right direction,¡± he said, adding: ¡°However, I think it would be a bit cavalier to all of a sudden say, ¡®We¡¯re completely through with [the pandemic].¡¯¡± | covid_4347 | null |
C_2.2 | Claims_Covid_C2.2_183 | Evidence_Covid_C2.2_1097 | Dr. Fauci: A new, more dangerous Covid variant could emerge this winter | N | null | Fauci pointed to the summer of 2021, when the U.S. saw similarly low pandemic trends, only for the omicron variant to emerge and cause a record-breaking surge in cases last winter. | covid_4347 | null |
C_2.2 | Claims_Covid_C2.2_183 | Evidence_Covid_C2.2_1098 | Dr. Fauci: A new, more dangerous Covid variant could emerge this winter | N | null | Emerging research suggests that some new subvariants, including one called BA.4.6, appear to evade immunity even more effectively than BA.5 ¡ª though it¡¯s unclear whether any of them will overtake BA.5 as the country¡¯s dominant Covid strain. | covid_4347 | null |